Stockscreener 앱 받기
6.80
2.41%
0.16
시간 외 거래:
6.80
전일 마감가:
$6.64
열려 있는:
$6.67
하루 거래량:
424.93K
Relative Volume:
0.89
시가총액:
$342.66M
수익:
$230.47M
순이익/손실:
$30.28M
주가수익비율:
11.15
EPS:
0.61
순현금흐름:
$38.86M
1주 성능:
+0.15%
1개월 성능:
+8.28%
6개월 성능:
+39.63%
1년 성능:
+143.73%
1일 변동 폭
$6.48
$6.83
1주일 범위
$6.37
$7.05
52주 변동 폭
$2.575
$7.285
Puma Biotechnology Inc Stock (PBYI) Company Profile
명칭
Puma Biotechnology Inc
전화
(424) 248-6500
주소
10880 WILSHIRE BLVD., LOS ANGELES, CA
Compare PBYI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
6.80 | 334.60M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-28 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Underperform |
| 2019-10-08 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-05-10 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-01-17 | 개시 | Leerink Partners | Mkt Perform |
| 2019-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2018-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-11-02 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-17 | 개시 | Goldman | Sell |
| 2018-05-11 | 재확인 | Stifel | Buy |
| 2017-11-10 | 재확인 | Citigroup | Buy |
| 2017-11-10 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | 재확인 | Stifel | Buy |
| 2017-09-11 | 재확인 | Credit Suisse | Outperform |
| 2017-07-10 | 재개 | Leerink Partners | Outperform |
| 2017-06-06 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | 재확인 | RBC Capital Mkts | Sector Perform |
모두보기
Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Re - pharmiweb.com
Puma Biotechnology sets Feb. 26 call on 2025 financial results - Stock Titan
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Fund Flows: Is Puma Biotechnology Inc undervalued by DCF analysisTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 4, 2026 - BioSpace
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule - TradingView
Puma Biotechnology (PBYI) Price Target Increased by 42.86% to 5.10 - Nasdaq
Investor Mood: How does Puma Biotechnology Inc. compare to its peersRisk Management & Risk Controlled Stock Alerts - baoquankhu1.vn
Published on: 2026-02-03 15:38:46 - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Buys 159,200 Shares of Puma Biotechnology, Inc. $PBYI - MarketBeat
Revenue Check: Is Puma Biotechnology Inc. stock suitable for long term investing - mfd.ru
Hedge Fund Bets: Is FONAR Corporation exposed to currency risks2025 Technical Patterns & Consistent Return Strategy Ideas - baoquankhu1.vn
Surprises Report: Will Puma Biotechnology Inc benefit from rate cutsJuly 2025 Action & Verified Short-Term Plans - baoquankhu1.vn
Momentum Shift: Can CALC maintain sales growthEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand – Company AnnouncementFT.com - Financial Times
New Thai breast cancer drug helps HER2+ patients lower relapse risk - Stock Titan
Sentiment Review: How does Puma Biotechnology Inc compare to its peers2025 Institutional Moves & Safe Capital Growth Plans - baoquankhu1.vn
Zacks Research Issues Pessimistic Forecast for PBYI Earnings - MarketBeat
Ritholtz Wealth Management Raises Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
EPS Watch: How Puma Biotechnology Inc stock valuations compare to rivalsWeekly Stock Analysis & High Accuracy Trade Signal Alerts - Bộ Nội Vụ
Death Cross: Can Puma Biotechnology Inc stock beat analyst upgradesJuly 2025 Big Picture & High Accuracy Investment Signals - Bộ Nội Vụ
Investing in Puma Biotechnology (NASDAQ:PBYI) a year ago would have delivered you a 103% gain - Yahoo Finance
Investor Mood: What dividend safety score for Puma Biotechnology Inc. stock2025 Market Outlook & Weekly Watchlist of Top Performers - Bộ Nội Vụ
Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI By Investing.com - Investing.com UK
Will Puma Biotechnology Inc. stock keep outperforming rivalsTrade Risk Report & AI Enhanced Execution Alerts - Улправда
Puma Biotechnology (NASDAQ:PBYI) CEO Sells $105,910.56 in Stock - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Insider Douglas Hunt Sells 3,973 Shares - MarketBeat
Puma biotech CFO Nougues sells $64k in shares By Investing.com - Investing.com Australia
Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k By Investing.com - Investing.com Australia
Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI - Investing.com
Puma biotech CFO Nougues sells $64k in shares - Investing.com
Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k - Investing.com
Will Puma Biotechnology Inc. stock continue dividend increasesEarnings Trend Report & Reliable Price Breakout Signals - Улправда
Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Puma Biotechnology reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Puma Biotechnology Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - sharewise.com
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - BioSpace
Puma Biotechnology Added to Nasdaq Biotechnology Index - marketscreener.com
If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity - Yahoo Finance
How Puma Biotechnology Inc. stock reacts to oil pricesPortfolio Value Report & Low Risk High Reward Trade Ideas - Улправда
What dividend safety score for Puma Biotechnology Inc. stockJuly 2025 Momentum & Long-Term Growth Portfolio Plans - Улправда
What analyst consensus says on Puma Biotechnology Inc. stock2025 Buyback Activity & Expert Curated Trade Setups - Улправда
History Review: How Puma Biotechnology Inc. stock reacts to oil pricesWeekly Risk Report & AI Driven Stock Reports - Улправда
Puma Biotechnology Inc (PBYI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):